Literature DB >> 10651945

Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix.

R Hershkoviz1, H Schor, A Ariel, I Hecht, I R Cohen, O Lider, L Cahalon.   

Abstract

We have found previously that disaccharides (DS) enzymatically generated from heparin or heparan sulphate can modulate tumour necrosis factor-alpha (TNF-alpha) secretion from immune cells in vitro and cell-mediated immune reactions in vivo. Here, we show that such DS can modulate the adhesion and migration of human T cells. We found that certain heparin- and heparan sulphate-derived DS induced, in a dose-dependent manner, the adhesion of human T cells to both extracellular matrix (ECM) and immobilized fibronectin (FN); maximal T-cell adhesion occurred with 1 ng/ml of DS. The levels of T-cell adhesion to ECM that were induced by the tested DS molecules resembled those induced by the prototypic chemokine, macrophage inflammatory protein 1beta (MIP-1beta). However, the kinetics of DS-induced T-cell adhesion to FN resembled that induced by phorbol myristate acetate (PMA), but not that induced by MIP-1beta. This adhesion appeared to involve beta1 integrin recognition and activation, and was associated with specific intracellular activation pathways. Although a first exposure of T cells to certain DS molecules appeared to result in cell adhesion, a subsequent exposure of T cells to pro-adhesive chemokines, such as MIP-1beta or RANTES, but not to other pro-adhesive stimuli, for example interleukin-2 or CD3 cross-linking, resulted in inhibition of T-cell adhesion to and chemotactic migration through FN. Hence, we propose that the breakdown products of tissues generated by inflammatory enzymes are part of an intrinsic functional programme, and not necessarily molecular waste. Moreover, because the DS molecules exert their modulatory functions within a limited time, it appears that the historical encounters of the tissue-invading cells with the constituents of inflamed loci may dictate the cells' behaviour upon subsequent exposure to proinflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651945      PMCID: PMC2327123          DOI: 10.1046/j.1365-2567.2000.00931.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

Review 1.  The cell biology of leukocyte-mediated proteolysis.

Authors:  C A Owen; E J Campbell
Journal:  J Leukoc Biol       Date:  1999-02       Impact factor: 4.962

Review 2.  Heparin or heparan sulfate--what is the difference?

Authors:  U Lindahl; L Kjellén
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

3.  Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.

Authors:  R Fridman; O Lider; Y Naparstek; Z Fuks; I Vlodavsky; I R Cohen
Journal:  J Cell Physiol       Date:  1987-01       Impact factor: 6.384

4.  Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta.

Authors:  D Gilat; R Hershkoviz; Y A Mekori; I Vlodavsky; O Lider
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

Review 5.  Role of heparan sulfate in immune system-blood vessel interactions.

Authors:  N S Ihrcke; L E Wrenshall; B J Lindman; J L Platt
Journal:  Immunol Today       Date:  1993-10

6.  Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity.

Authors:  K Bezouska; C T Yuen; J O'Brien; R A Childs; W Chai; A M Lawson; K Drbal; A Fiserová; M Pospísil; T Feizi
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

7.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Authors:  L M Webb; M U Ehrengruber; I Clark-Lewis; M Baggiolini; A Rot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

8.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Regulation of murine splenocyte responses by heparan sulfate.

Authors:  L E Wrenshall; F B Cerra; A Carlson; F H Bach; J L Platt
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

Review 10.  Cytokines in context.

Authors:  C Nathan; M Sporn
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

View more
  2 in total

Review 1.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

Review 2.  Intestinal fibrosis in IBD--a dynamic, multifactorial process.

Authors:  Florian Rieder; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.